1,854
Views
7
CrossRef citations to date
0
Altmetric
Research Paper

Regulating COX10-AS1 / miR-142-5p / PAICS axis inhibits the proliferation of non-small cell lung cancer

, , &
Pages 4643-4653 | Received 18 Jun 2021, Accepted 14 Jul 2021, Published online: 29 Jul 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Articles from other publishers (6)

Ge Zhang, Xiang Tao, Bao-wei Ji & Jie Gong. (2024) Long Non-coding RNA COX10-AS1 Promotes Glioma Progression by Competitively Binding miR-1-3p to Regulate ORC6 Expression. Neuroscience 540, pages 68-76.
Crossref
Yufeng Li, Lingyun Zhu, Jiaqi Mao, Hongrui Zheng, Ziyi Hu, Suisui Yang, Tianyu Mao, Tingting Zhou, Pingping Cao, Hongshuai Wu, Xuerong Wang, Jing Wang, Fan Lin & Hua Shen. (2024) Genome‐scale CRISPR–Cas9 screen identifies PAICS as a therapeutic target for EGFR wild‐type non‐small cell lung cancer . MedComm 5:3.
Crossref
Parisa Zareifar, Hani Moslem Ahmed, Pouya Ghaderi, Yalda Farahmand, Negin Rahnama, Romina Esbati, Ali Moradi, Omid Yazdani & Yasin Sadeghipour. (2024) miR‐142‐3p/5p role in cancer: From epigenetic regulation to immunomodulation. Cell Biochemistry and Function 42:2.
Crossref
Anqi Huo & Xiangyang Xiong. (2023) PAICS as a potential target for cancer therapy linking purine biosynthesis to cancer progression. Life Sciences 331, pages 122070.
Crossref
Jie Sun, Xiaohua Li, Jun Yin, Xin Chen, Zheng Zhu, Runda Wu, EnQiao Yu & Zhongqi Mao. (2023) Long non coding RNA COX10-DT promotes the progression of breast cancer via the COX10-DT/miR-206/BDNF axis. Biochemical and Biophysical Research Communications 639, pages 46-53.
Crossref
Jie Ding, Yifan Wen, Xu Yuan & Xianghuo He. (2022) MicroRNA-mediated reprogramming of glucose, fatty acid and amino acid metabolism in cancer. Genome Instability & Disease 4:2, pages 47-69.
Crossref